N-Desmethyl Levofloxacin is a structurally related impurity derived from Levofloxacin via N-demethylation at the piperazin-1-yl moiety. It retains the quinolone-4-carboxylic acid core, fluorine substitution at C-6, and a methoxy group at C-8, but features a dealkylated piperazine ring. This modification alters its hydrophobicity and hydrogen-bonding capacity compared to the parent drug. It arises as a synthetic byproduct during Levofloxacin production or via oxidative degradation pathways. It serves as a critical HPLC reference standard for quantifying process-related impurities in Levofloxacin active pharmaceutical ingredients.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| USP | 1362114 โ | 25 mg | USD 948.00 |
C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCNCC4)F)C(=O)O
InChI=1S/C17H18FN3O4/c1-9-8-25-16-13-10(15(22)11(17(23)24)7-21(9)13)6-12(18)14(16)20-4-2-19-3-5-20/h6-7,9,19H,2-5,8H2,1H3,(H,23,24)/t9-/m0/s1
WKRSSAPQZDHYRV-VIFPVBQESA-N